المؤلفون: Grzegorz Redlarski, Sławomir Kozieł, Marek Krawczuk, Janusz Siebert, Marek Tałałaj, Aleksander Pałkowski, Piotr Tojza, Zuzanna Cieślikowska, Leszek Sławomir Litzbarski

المصدر: International Journal of Occupational Medicine and Environmental Health, Vol 37, Iss 2, Pp 205-219 (2024)

مصطلحات موضوعية: cancer therapy, diagnosis, 3d body scanning, body surface area formulae, bsa calculations, drugs dosage, Medicine

وصف الملف: electronic resource

Relation: https://ijomeh.eu/An-improvement-of-body-surface-area-formulas-using-the-3D-scanning-technique,186066,0,2.html; https://doaj.org/toc/1232-1087; https://doaj.org/toc/1896-494X

URL الوصول: https://doaj.org/article/df0b98b3bc2c4a409e4431420aa59499

المؤلفون: Bos, Gerrit, 1925-, Bos, Gerrit, 1925-, Käs, Fabian

المساهمون: Käs, Fabian

المصدر: Aleph; Historical Studies in Science & Judaism. 22,1-2 (2022) 157-182

مصطلحات موضوعية: Manuscripts, Hebrew, Manuscripts, Arabic, Drugs -- Dosage, Pharmacy -- History, Medicine, Arab, Jews -- Medicine

URL الوصول: https://uli.nli.org.il/discovery/search?query=issn,exact,1565-1525&tab=LibraryCatalog&search_scope=MyInstitution&vid=972NNL_ULI_C:MAIN

المؤلفون: Barbosa Barbosa, Helber de Jesús, Zambrano Bareño, Paula Valentina

مصطلحات موضوعية: 610 - Medicina y salud::615 - Farmacología y terapéutica, Drugs -- Physiological effect, Drugs -- Bioavailability, Drugs -- Dosage forms, Drug delivery devices, Biopharmaceutics, Drug carriers (Pharmacy), Drugs – Metabolism, Pharmacokinetics, Medicamentos -- Biodisponibilidad, Formas farmacéuticas, Medicamentos -- Sistemas de administración, Medicamentos -- Efectos fisiológicos, Biofarmacia, Vehículos de medicamentos, Medicamentos -- Metabolismo, Farmacocinética, Vías de administración de medicamentos, Preparaciones farmacéuticas -- Administración & dosificación, Absorción fisicoquímica -- Efectos de los fármacos, Drug administration routes, Pharmaceutical Preparations -- administration & dosage, Absorption, Physicochemical -- drug effects, Forma farmacéutica, Fármaco, Vía de administración, Absorción, Medicamentos -- Propiedades de transporte, Drugs -- Transport properties

جغرافية الموضوع: Colombia

وصف الملف: 194 páginas; application/pdf

Relation: Colección Notas de clase. Farmacia; [1] Shargel L, Yu A. Introduction to Biopharmaceutics and Pharmacokinetics. En: Shargel L y Yu A, editores. Applied biopharmaceutics & pharmacokinetics. Estados Unidos: McGraw-Hill; 2016. p. 1–414; [2] Bergersen B, Krug E, Goth A. Routes of administration. En: Pharmacology in nursing. Estados Unidos: C. V. Mosby Company, 1966, p. 78.; [3] Wagner JG. Relaciones entre concentración de medicamento y respuesta y cinética de la respuesta farmacológica. En: Farmacocinética clínica. Barcelona: Reverté; 1983, p. 352.; [4] Sinko P. Biopharmaceutics. En: Martin’s physical pharmacy and pharmaceutical sciences: physical chemical and biopharmaceutical principles in the pharmaceutical sciences. Filadelfia: Lippincott Williams & Wilkins; 2006, p. 259.; [5] Lilley LL, Snyder JS, Rainforth-Collins S. Pharmacology basics. En: Pharmacology and the nursing process. San Luis, Missouri: Elsevier; 2014, p. 17–36.; [6] Edmunds MW, Mayhew MS. Special populations: Pregnant and nursing women. En: Pharmacology for the Primary Care Provider. San Luis, Missouri: Elsevier; 2014, p. 70–86.; [7] Aïche JM, Guyot AM, Devissaguet JPh. Introducción a la farmacia galénica. En: Biofarmacia. México. El Manual Moderno; 1983, p. 3–427.; [8] Parrado R. Aspectos biofarmacéuticos y farmacocinéticos de los medicamentos. En: Farmacología clínica. Bogotá: El Manual Universitario; 1984, p. 4.; [9] Brunton L, Knollman C. Farmacocinética: la dinámica de la absorción, distribución, acción y eliminación de los fármacos. En: Goodman & Gilman: Las bases farmacológicas de la terapéutica. México: McGraw Hill; 2011, p. 20–24.; [10] Anónimo. Oral/peroral [Internet]. [Consultado 2020 marzo] Disponible en: https://www.proz.com/kudoz/english-to-8danish/medical-general/690406-oral-peroral.html; [11] Shiel WC. Medical Definition of p.o. [Internet]. [Consultado 2020 marzo]. Disponible en: https://www.medicinenet.com/script/main/art.asp?articlekey=8310.; [12] Anónimo. Definición de tracto digestivo. [Internet]. [Consultado 2020 marzo]. Disponible en: https://www.cancer.gov/espanol/publicaciones/diccionario/def/tubo-gastrointestinal; [13] Villegas G. Esfínteres cardias [Internet]. [Consultado 2020 marzo]. Disponible en: http://morfofisiologiaclinica.blogspot.com/2012/11/esfinteres-cardias.html; [14] Mazon A, Ribas C, Yafar M, Alfaro V, Oliva J, Farias F. Factibilidad de detección de parásitos en el cuerpo humano con el uso de ultrasonido. Universidad Nacional de San Juan. [Internet]. [Consultado mayo 2020] https://dea.unsj.edu.ar/ultrasonido/pdfs/Trabajos%20finales/Bio/Estudio%20deteccion%20de%20parasitos_2017.pdf; [15] Anónimo. Anatomía y función de sistema digestivo. [Internet]. [Consultado marzo 2020]. Disponible en: https://sites.google.com/site/preupsubiologia/anatomiayfunciondesistemadigestivo; [16] Anónimo. Atlas anatómico: aparato digestivo. [Internet]. [Consultado 2020 marzo]. Disponible en: https://www.saludalia.com/atlas/aparato-digestivo; [17] American Cancer Society, American Joint Committee on Cancer. Etapas del cáncer colorrectal [Internet]. [Consultado marzo 2020]. Disponible en: https://www.cancer.org/es/cancer/cancer-de-colon-o-recto/deteccion-diagnostico-clasificacion-por-etapas/clasificacion-de-la-etapa.html; [18] Berlin M. Predicting oral absorption of poorly soluble weakly basic drugs [Internet]. [Consultado marzo 2020]. Disponible en: https://cuvillier.de/uploads/preview/public_file/9689/9783736991460_Leseprobe.pdf; [19] Gorenstein C. Conceitos gerais de psicofarmalogia [Internet]. [Consultado marzo 2020]. Disponible en: http://www.icb.usp.br/farmaco/uploads/conc-gerais-psicofarmaco-cg-2011-psico-pdf4eb3ebeb6305e.pdf; [20] Rang HP, Ritter JM, Flower RJ, Henderson G. Métodos y mediciones en farmacología. En: Rang y Dale, editores. Farmacología. Barcelona: Elsevier; 2016. p. 109–112.; [21] Khan Academy. Difusión y transporte pasivo [Internet]. [Consultado febrero 2020]. Disponible en: https://es.khanacademy.org/science/biology/membranes-and-transport/passive-transport/a/diffusion-and-passive-transport; [22] Anónimo. Diverticulitis, polyps, and colon cancer: what you need to understand! [Internet]. [Consultado marzo 2020]. Disponible en: https://medicienterprises.com/2015/11/28/show-236/; [23] Servicio Navarro de Salud Osasunbidea. Formas farmacéuticas de liberación modificada y estereoisómeros ¿Nos aportan algo en la práctica clínica? Boletín de Información Farmacoterapéutica de Navarra. 2005; 13(1): 2-9.; [24] Springernature. First pass effect [Internet]. [Consultado marzo 2020]. Disponible en: https://media.nature.com/full/nature-assets/nrd/journal/v1/n1/images/nrd705-f1.gif; [25] Plá Delfina JM, del Pozo Ojeda A. Fase de incorporación o absorción. En: Manual de Iniciación a la Biofarmacia (Farmacocinética Aplicada). Barcelona: Universidad de Barcelona - Departamento de Farmacia Galénica; 1974. p. 65–83.; [26] García Casallas JC. Uso seguro de medicamentos farmacocinética clínica [Internet]. [Consultado marzo 2020]. Disponible en: http://clinicalevidence.pbworks.com/w/file/fetch/68206463/farmacocinetica%20clini; [27] Smart JD. Buccal drug delivery. Expert opinion on drug delivery. 2005; (2): p. 507.; [28] Anónimo. The buccal route of drug administration [Internet]. [Consultado marzo 2020]. Disponible en: http://medication123.blogspot.com/2013/12/the-buccal-route-of-drug-administration.html; [29] Reedijk J, Dalcanale E, Krebs B, Marquardt R, Morbidelli M, Nakai H, Panza L, Poole C, Quack M, Wandelt K. Reference module in chemistry, molecular sciences and chemical engineering. Ámsterdam: Elsevier; 2013.; [30] Sheoran R. Fast dissolving oral films: A review with future prospects. International Journal of Pharmacy & Pharmaceutical Research. 2018; 12(2): 15-32.; [31] Terranova A. OsteoLab [Internet]. [Consultado marzo 2020]. Disponible en: https://www.osteolab.net/plesso-pterigoideo/; [32] Pacheco LF. Membranas celulares y transporte [Internet]. [Consultado marzo 2020]. Disponible en: http://163.178.103.176/Fisiologia/gen_activ_basica5_1.html; [33] Sonia TA, Sharma CP. Routes of administration of insulin. En: Oral delivery of insulin. Cambridge: Elsevier; 2014. p. 59–112.; [34] Narang N, Sharma J. Sublingual mucosa as a route for systemic drug delivery. International Journal of Pharmacy and Pharmaceutical Sciences. 2010; 3(2): 18-22.; [35] Khan AB, Kingsley T, Caroline P. Sublingual tablets and the benefits of the sublingual route of administration. Journal of Pharmaceutical Research. 2017; 16(3): 257-267.; [36] Anónimo. Innovative drug delivery [Internet]. [Consultado marzo 2020]. Disponible en: https://aquestive.com/innovative-drug-delivery-pharmfilm/; [37] Maheshwari R, Kuche K, Mane A, Chourasiya Y, Tekade M, Tekade RK. Manipulation of physiological processes for pharmaceutical product development. En: Dosage form design considerations. Kuala Lumpur: Elsevier; 2018. p. 701–729.; [38] Crumbie L. Tongue [Internet]. [Consultado marzo 2020]. Disponible en: https://www.kenhub.com/en/library/anatomy/tongue; [39] Dowd FJ. Pharmacokinetics: the absorption, distribution, and fate of drugs. En: Johnson BS, Mariotti AJ, editores. Pharmacology and therapeutics for dentistry. Estados Unidos: Elsevier; 2017. p. 15–43.; [40] Kelly JS. Topical ophthalmic drug administration: a practical guide. British Journal of Nursing. 1994; 3(10): 518-520.; [41] Anónimo. Topical drug dosage forms for eye conditions. The Pharmaceutical Journal. 2017; (1).; [42] Winslow T. Anatomía del ojo [Internet]. [Consultado abril 2020]. Disponible en: https://visualsonline.cancer.gov/details.cfm?imageid=12366; [43] Gaudana R, Ananthula HK, Parenky A, Mitra AK. Ocular drug delivery. The AAPS journal. 2010; 12(3): 348-60.; [44] Dubald M, Bourgeois S, Andrieu V, Fessi H. Ophthalmic drug delivery systems for antibiotherapy-a review. Pharmaceutics. 2018; 10(1): 10.; [45] Baranowski P, Karolewicz B, Gajda M, Pluta J. Ophthalmic drug dosage forms: characterisation and research methods. The Scientific World Journal. 2014, 861: 1-14.; [46] Wiesner L, Prause M, Lovsin Barle E. Topical otic drugs in a multi-purpose manufacturing facility: a guide on determination and application of permitted daily exposure (PDE). Pharmaceutical Development and Technology. 2018; 23 (261).; [47] Liu X, Li M, Smyth H, Zhang F. Otic drug delivery systems: formulation principles and recent developments. Drug Development and Industrial Pharmacy. 2018; 44(9): 1395-1408. Disponible en: http://dx.doi.org/10.1080/03639045.2018.1464022.; [48] Batchelor H. Nasal, ocular and otic drug delivery. En: Pediatric formulations. Nueva York: Srpinger; 2014. p. 273–301.; [49] Nardone H. How to give your child ear drops [Internet]. [Consultado abril 2020]. Disponible en: https://www.uwhealthkids.org/kidshealth/en/parents/ear-drops.html/; [50] Altiorem. Tapones de cera y limpieza de oídos [Internet]. Otorrinolaringología Madrid. Medicina Subacuática y Estética. 2017 [Consultado abril 2020]. Disponible en: https://altiorem.com/informacion-pacientes-patologias/patologia-general-orl/tapones-de-cera/; [51] Carter A. How to use nasal spray [Internet]. [Consultado abril 2020]. Disponible en: https://www.healthline.com/health/general-use/how-to-use-nasal-spray; [52] Marx D, Williams G, Birkhoff M. Intranasal drug administration is an attractive delivery route for some drugs. En: Drug discovery and development - From molecules to medicine. Londres: InTech; 2015. p. 299-320.; [53] Türker S, Onur E, Ozer Y. Nasal route and drug delivery systems. Pharmacy World & Science. 2004; 26(3): 137-42; [54] Lluch-Colomer A, García-García M, Montero-Balosa JM, Gonzalez-Alonso. Vías de administración de los medicamentos. En: Conocimientos básicos del medicamento y su utilización. Madrid: Sociedad Española de Farmacia Hospitalaria; 2017. p. 1-62.; [55] Anónimo. Treating bladder cancer intravesical therapy [Internet]. [Consultado abril 2020]. Disponible en: https://www.mountnittany.org/articles/healthsheets/6588; [56] GuhaSarkar S, Banerjee R. Intravesical drug delivery: Challenges, current status, opportunities and novel strategies. Journal of Controlled Release: Official Journal of the Controlled Release Society. 2010; 148(2): 147-159.; [57] Girona L, Conejero J. Urología. En J. Bonal-Falgas et al., editores. Farmacia hospitalaria. Madrid: Sociedad Española de Farmacia Hospitalaria; 2003. P. 1601–1624.; [58] Lee M, Desai A. Rectal, vaginal, and urethral delivery. En Archana D y Mary L, editoras. Gibaldi’s drug delivery systems in pharmaceutical care. Portland: American Society of Health - System Pharmacists; 2007. p. 95-100.; [59] Stapleton A. Definición y hechos para la infección de la vejiga - adultos [Internet]. National Institute of Diabetes and Digestive and Kidney Diseases [Consultado marzo 2020]. Disponible en: https://www.niddk.nih.gov/health-information/informacion-de-la-salud/enfermedades-urologicas/infecciones-vejiga/definicion-hechos; [60] Anónimo. Absorption from the urinary tract. JAMA: The Journal of the American Medical Association. 1923; 81(21): 1791-1792. Disponible en: http://dx.doi.org/10.1001/jama.1923.02650210057017; [61] Abhang P, Momin M, Inamdar M, Kar S. Transmucosal drug delivery-an overview. Drug Delivery Letters. 2014; 4(1): 26-37.; [62] Mittal R, Pan DR, Parrish JM, Huang EH, Yang Y, Patel AP, Malhotra AK, Mittal J, Chhibber S, Harja K. Local drug delivery in the urinary tract: current challenges and opportunities. Journal of Drug Targeting. 2018; 26 (8): 658-669.; [63] Verma P, Thakur A, Deshmukh A, Jha S. Routes of drug administration. International Journal of Pharmaceutical Studies and Research. 2010; 1: 54-59.; [64] Kirchin V, Page T, Keegan PE, Atiemo K, Cody JD, McClinton S. Urethral injection therapy for urinary incontinence in women. The Cochrane Database of Systematic Reviews. 2017; 1 (2012): 1-55.; [65] Van Kerrebroeck P, Ter Meulen F, Farrelly E, Larsson G, Edwall L, Fianu-Jonasson A. Treatment of stress urinary incontinence: recent developments in the role of urethral injection. Urological Research. 2003; 30(6): 356-362.; [66] American Urological Association. Intravesical administration of therapeutic medication [Internet]. [Consultado abril 2020]. Disponible en: https://www.auanet.org/guidelines/intravesical-administration-of-therapeutic-medication; [67] Askhok V, Kumar R, Murali D, Chatterjee A. A review on vaginal route as a systemic drug delivery. Critical Review in Pharmaceutical Sciences. 2012; 1: 1-19.; [68] Dobaria N, Mashru R, Vadia NH. Vaginal drug delivery systems: A review of current status, East and Central African. Journal of Pharmaceutical Sciences. 2008; 10: 3-13.; [69] Anónimo. Administering vaginal medication [Internet]. [Consultado 2020 abril]. Disponible en: https://nursing-skills.blogspot.com/2013/12/administering-vaginal-medication.html; [70] Vermani G. The scope and potential of vaginal drug delivery. Pharmaceutical Science & Technology Today. 2000; 3 (359); [71] Anónimo. Capas de tejido vaginal [Internet]. Mayo Clinic. 2023 [Consultado abril 2020]. Disponible en: https://www.mayoclinic.org/es-es/diseases-conditions/vaginal-cancer/multimedia/layers-of-vaginal-tissue/img-20008246; [72] Alexander NJ, Baker E, Kaptein M, Karck U, Miller L, Zampaglione E. Why consider vaginal drug administration? Fertility and Sterility. 2004; 82(1): 1-12.; [73] Purohit TJ, Hanning SM, Wu Z. Advances in rectal drug delivery systems. Pharmaceutical Development and Technology. 2018; 23(10): 942-952.; [74] Javed M. Medication administration [Internet]. [Consultado abril 2020]. Disponible en: https://www.wowslides.com/users/javedahmed/projects/Medication-Administration?slide=9; [75] Romera M. Anatomía rectal [Internet]. [Consultado abril 2020]. Disponible en: https://manuelromera.com/anatomia-rectal; [76] Van Hoogdalem E, de Boer DG, Breimer D. Pharmacokinetics of rectal drug administration, Part I. General considerations and clinical applications of centrally acting drugs. Clinical Pharmacokinetics. 1991; 21(1): 11-26.; [77] de Boer AG, Moolenaar F, de Leede LG, Breimer DD. Rectal drug administration: clinical pharmacokinetic considerations. Clinical Pharmacokinetics. 1982; 7(4): 285-311.; [78] Anónimo. Tratar mal el asma puede afectar los pulmones de por vida [Internet]. infobae. 2017. [Consultado abril 2020]. Disponible en: https://www.infobae.com/2011/07/01/590924-tratar-mal-el-asma-puede-afectar-los-pulmones-vida/; [79] Groneberg DA, Witt C, Wagner U, Chung KF, Fischer A. Fundamentals of pulmonary drug delivery. Respiratory Medicine. 2003; 97(4):382-387.; [80] Patil JS, Sarasija S. Pulmonary drug delivery strategies: A concise, systematic review. Lung India: Official Organ of Indian Chest Society. 2012; 29(1): 44-49.; [81] Anónimo. Sistema respiratorio humano [Internet]. Blogspot.com. [Consultado abril 2020]. Disponible en: http://biologia-test.blogspot.com/2014/07/sistema-respiratorio-humano.html; [82] Stillwell W. Membrane transport. En: An introduction to biological membranes. España: Elsevier; 2016. p. 423-451.; [83] de la Fuente-Rodríguez A, Hoyos-Valencia Y, Gutiérrez-García L, Muñoz-Esteban C, Sevillano-Marcos A, León-Rodríguez C, Mora-Sáez E, Fernández-Martín C. Guía rápida de fármacos en soporte vital avanzado. Semergen. 2009; 35: p. 376-379.; [84] Mukherjee B, Paul P, Dutta L, Chakraborty S, Dhara M, Mondal L, Sengupta S. Pulmonary administration of biodegradable drug nanocarriers for more efficacious treatment of fungal infections in lungs: Insights based on recent findings. En: Multifunctional systems for combined delivery, biosensing and diagnostics. Bucarest: Elsevier; 2017. p. 261–280.; [85] Khan I, Elhissi A, Shah M, Alhnan MA, Ahmed W. Liposome-based carrier systems and devices used for pulmonary drug delivery. En: Biomaterials and medical tribology. Reino Unido: Elsevier; 2013. p. 395-443.; [86] Petrilli R, Lopez RF. Physical methods for topical skin drug delivery: Concepts and applications. Brazilian Journal of Pharmaceutical Sciences. 2018; 54(Special): 1-19.; [87] Anónimo. Topical and transdermal – getting under your skin. [Internet]. Altasciences. [Consultado abril 2020]. Disponible en:https://www.altasciences.com/topical-and-transdermal-e28093-getting-under-your-skin; [88] Roohnikan M, Laszlo E, Babity S, Brambilla D. A snapshot of transdermal and topical drug delivery research in Canada. Pharmaceutics. 2019; 11(6):256.; [89] Anónimo. Anatomía de la piel [Internet]. Stanford Medicine Children’s Health. [Consultado abril 2020]. Disponible en: https://www.stanfordchildrens.org/es/topic/default?id=anatomyoftheskin-85-P04436; [90] Bhowmik D, Gopinath H, Pragati Kumar B, Duraivel S, Sampath Kumar K. Recent advances in novel topical drug delivery system. The Pharma Innovation. 2012; 1 (9): 12-31.; [91] Llovet-Traveset E. Parches transdérmicos [Internet]. [Consultado mayo 2020]. Disponible en: https://www.cedimcat.info/index.php?option=com_content&view=article&id=201:parches-transdermicos&catid=49:administracion-de-los-medicamentos=es; [92] Loyola Y. Jeringas - agujas [Internet]. Blogspot.com. [Consultado mayo 2020]. Disponible en: http://aprendiz-de-medico.blogspot.com/2018/07/; [93] Vásquez AG. Tipos de agujas hipodérmicas para enfermería [Internet]. [Consultado mayo 2020]. Disponible en: https://www.iberomed.es/blog/2018/02/09/tipos-de-agujas-hipodermicas-para-enfermeria/; [94] Atensalud. Farmacología: La vía parenteral [Internet]. [Consultado mayo 2020]. Disponible en: http://www.atensalud.com/2017/04/farmacologia-geriatrica-la-via.html; [95] Generación Elsevier. Vía parenteral: 4 formas de administración de inyectables [Internet]. Elsevier; 2017. [Consultado mayo 2020]. Disponible en: https://www.elsevier.com/es-es/connect/medicina/via-parenteral-4-formas-de-administracion-de-inyectables; [96] Carbajal B, Mayans E, Rufo R, Silvera F. Pauta de colocación de catéteres umbilicales. Archivos de Pediatría del Uruguay. 2016; 87: 263-268.; [97] Maddison JE, Page SW, Dyke TM. Clinical pharmacokinetics. En: Small animal clinical pharmacology. Reino Unido: Elsevier; 2008. p. 27-40.; [98] Claassen, V. Intravenous drug administration. En: Neglected factors in pharmacology and neuroscience research: Volume 12: Biopharmaceutics, animal characteristics, maintenance, testing conditions. Ámsterdam: Elsevier; 1994. p. 5-22.; [99] Almeida JI. Venous Anatomy . En: Atlas of endovascular venous surgery. Philadelphia: Elsevier; 2012. p. 1-20.; [100] Vijayakumar A, Sharon E, Teena J, Nobil S, Nazeer I. A clinical study on drug-related problems associated with intravenous drug administration. Journal of Basic and Clinical Pharmacy. 2014; 5 (2): 49-53.; [101] Palleja E, López M, Jiménez P. Catéteres venosos de inserción periférica (PICC): un avance en las terapias venosas de larga permanencia. Nutrición Clínica en Medicina. 2017; (11): 114-127.; [102] Struys M, Sahinovic M, Lichtenbelt B, Vereecke H, Absalom A. Optimizing intravenous drug administration by applying pharmacokinetic/pharmacodynamic concepts. British Journal of Anaesthesia. 2011; 107(1): 38-47.; [103] Import Vélez. Esquema equipo de venoclisis [Internet]. [Consultado mayo 2020]. Disponible en: http://importvelez.com.ar/portfolio/equipos-de-venoclisis/esquema-equipo-de-venoclisis-01/; [104] Joshi S, Emala CW, Pile-Spellman J. Intra-arterial drug delivery: A concise review. Journal of Neurosurgical Anesthesiology. 2007; 19: 111-119.; [105] Mercadante A, Raja A. Anatomy, arteries, statPearls. Estados Unidos: StatPearls Publishing LLC l; 2019.; [106] Anónimo. Corte transversal de una arteria [Internet]. Medlineplus.gov. [Consultado julio 2020]. Disponible en: https://medlineplus.gov/spanish/ency/esp_imagepages/19194.htm; [107] Avgeropoulos NG, Newton HB. Clinical pharmacology of brain tumor chemotherapy. Estados Unidos: Elsevier; 2018.; [108] Hong K, Khwaja A, Liapi E, Torbenson MS, Georgiades CS, Geschwind JF. New intra-arterial drug delivery system for the treatment of liver cancer: Preclinical assessment in a rabbit model of liver cancer. Clinical Cancer Research. 2006; 12(8): 2563-2567.; [109] Berridge BR, Bolon B, Herman E. Skeletal Muscle System. En: Wallig M, Haschek W, Rousseaux C, Bolon B. Fundamentals of toxicologic pathology. Estados Unidos: Elsevier; 2018. p. 195-212.; [110] Anónimo. Sistema muscular [Internet]. [Consultado mayo 2020]. Disponible en: https://sites.google.com/site/fisiologiaucc/Sistema-muscular; [111] Vastus lateralis intramuscular injection site [Internet]. [Consultado mayo 2020]. Disponible en: https://classconnection.s3.amazonaws.com/847/flashcards/2140847/png/picture2-141F9027E7904830409.png; [112] Anónimo. Muscle anatomy. [Internet]. [Consultado mayo 2020]. Disponible en: http://droualb.faculty.mjc.edu/Course Materials/Elementary Anatomy and Physiology 50/Lecture outlines/muscle_anatomy.htm, may de 2020.; [113] Claassen V. Intramuscular drug administration. En: Neglected factors in pharmacology and neuroscience research: Volume 12: Biopharmaceutics, animal characteristics, maintenance, testing conditions. Ámsterdam: Elsevier; 1994. p. 23-34.; [114] Kadir F. Intramuscular and subcutaneous drug delivery: Encapsulation in liposomes and other methods to manipulate drug availability. Pharmacy World & Science. 1993; 15: 173-175.; [115] Stephens C. What is a subcutaneous injection? [Internet] Healthline. 2016. [Consultado mayo 2020]. Disponible en: https://www.healthline.com/health/subcutaneous-injection; [116] Haskell H. Histology of the skin. En: Busam K, editor. Dermatopathology. Nueva York: Elsevier; 2010. p. 1-8.; [117] Valle M, Zamorani MP. T Skin and subcutaneous tissue. En: Ultrasound of the Musculoskeletal System. Berlín: Springer; 2007. p. 19-43.; [118] Doyle GR, McCutcheon JA. 7.3 Intradermal and subcutaneous injections. En Doyle GR, McCutcheon JA, editores. Clinical procedures for safer patient care; 2015 [Internet]. [Consultado mayo 2020]. Disponible en: https://opentextbc.ca/clinicalskills/chapter/6-7-intradermal-subcutaneous-and-intramuscular-injections/; [119] Claaseen V. Subcutaneous drug administration. En: Neglected factors in pharmacology and neuroscience research: Volume 12: Biopharmaceutics, animal characteristics, maintenance, testing conditions. Ámsterdam: Elsevier; 1994. p. 35-45.; [120] Stoner KL, Harder H, Fallowfield LJ, Jenkins VA. Intravenous versus subcutaneous drug administration. Which do patients prefer? A Systematic Review, Patient. 2015; 8: 145-153.; [121] Anónimo. Injection into the dermal skin layer [Internet]. Idevax [Consultado mayo 2020]. Disponible en: https://novosanis.com/intradermal-injection; [122] Shrestha P, Stoeber B. Fluid absorption by skin tissue during intradermal injections through hollow microneedles. Scientific Reports. 2018; 8(13749): 1-13.; [123] Shah B. Dosage forms, routes and administration, and dispensing medications. En: Navigate course manager: the 21st century pharmacy technician. Estados Unidos: Jones & Bartlett; 2011. p. 79–112.; [124] Reichman E. Emergency medicine procedures. Estados Unidos: McGraw-Hill; 2013.; [125] Pedersen A, Jespersen H, Torp-Pedersen C. The place of intracardiac injections in the treatment of cardiac arrest. Drugs. 1991; 42(6):915-918.; [126] Buck ML, Wiggins BS, Sesler JM. Intraosseous drug administration in children and adults during cardiopulmonary resuscitation. Annals of Pharmacotherapy. 2007;41(10):1679-1686. Disponible en: http://dx.doi.org/10.1345/aph.1k168; [127] Farquhar-Smith P, Chapman S. Neuraxial (epidural and intrathecal) opioids for intractable pain. British Journal of Pain. 2012; (6): 25-35.; [128] Yartsev A. Pharmacokinetics of drugs in the epidural and subarachnoid space [Internet]. Deranged Physiology. 2018 [Consultado julio 2020]. Disponible en: https://derangedphysiology.com/main/cicm-primary-exam/required-reading/pharmacokinetics/Chapter%20417/pharmacokinetics-drugs-epidural-and-subarachnoid-space; [129] Aguilar J, Mendiola M, Sala-Blanch X. Bloqueo y anestesia epidural. 2005. p. 1-35. [consultado 2020 mayo]. Disponible en: https://www.yumpu.com/es/document/view/51547620/bloqueo-y-anestesia-epidural-i-dr-jose-l-aguilar-dr-ma-; [130] Rebollo-Manrique RE. Bloqueo subaracnoideo: Una técnica para siempre. Revista Mexicana de Anestesiologia. 2013; 36(1): 145-149.; [131] Zaragoza M, González-Miret M.N. Hemodiálisis, diálisis peritoneal y otras técnicas de depuración extrarenal. En: Santos Ramos B, Guerrero A. Administración de medicamentos: teoría y práctica. Madrid: Ediciones Díaz de Santos S.A; 1994. p. 283- 301; [132] Anónimo. Diálisis peritoneal [Internet]. Mayoclinic.org. 2019. [Consultado agosto 2020] Disponible en: https://www.mayoclinic.org/es-es/tests-procedures/peritoneal-dialysis/about/pac-20384725; [133] Anónimo. Peritoneo [Internet]. Dolopedia. 2019 [Consultado agosto 2020]. Disponible en: https://dolopedia.com/articulo/peritoneo; [134] Claassen V. Intraperitoneal drug administration. En: Neglected factors in pharmacology and neuroscience research: Volume 12: Biopharmaceutics, animal characteristics, maintenance, testing conditions. Ámsterdam: Elsevier. 1994; 12. p. 46-58.; [135] Ríos A, Gordillo ME, Bocanegra C, Maldonado JA, Prieto A. Administración nasal e inhalatoria. En: Santos Ramos B, Guerrero A. Administración de medicamentos: teoría y práctica. Madrid: Ediciones Díaz de Santos S.A.; 1994. p. 131-167.; [136] Anónimo. Intrapleural drug administration [Internet]. Nurse Key. 2016 [Consultado agosto 2020]. Disponible en: https://nursekey.com/intrapleural-drug-administration/; [137] Yildrim E. IPC (Intrapleural Permanent Tunnelled CHEST Catheter for MPE (Malignant Pleural Effusion) and Chylothorax [Internet]. [Consultado agosto 2020]. Disponible en: https://chestandlungsurgeon.com/ipc-intrapleural-permanent-tunnelled-chest-catheter-for-mpe-malignant-pleural-effusion-and-chylothorax/; [138] Smith N. Mesotelioma pleural, 2015 [Internet]. [Consultado agosto 2020]. Disponible en: https://www.cancercarewny.com/content.aspx?chunkiid=127536; [139] Gritsenko K, Tomajian S, Aquino M, KayeK AD. Inyecciones en articulaciones, tendones y nervios. En Sackheim K, editor, Manejo del dolor y cuidados paliativos. Springer. Nueva York: Springer; 2015. p. 365-436.; [140] Elsevier Connect. Apuntes de anatomía. Tipos de articulaciones: sinoviales y sólidas, 2018 [Internet]. Elsevier; 2018 [Consultado agosto 2020]. Disponible en: https://www.elsevier.com/es-es/connect/medicina/anatomia-tipos-articulaciones-sinoviales-y-solidas; https://repositorio.unal.edu.co/handle/unal/87111

الاتاحة: https://repositorio.unal.edu.co/handle/unal/87111

المؤلفون: Sánchez Artuñedo, David, Pié Padró, Savannah, Hermida López, Marcelino, Duch Guillen, María Amor, Beltrán Vilagrasa, Mercè

المساهمون: Universitat Politècnica de Catalunya. Institut de Tècniques Energètiques, Universitat Politècnica de Catalunya. IONHE - Ionising Radiation, Health and Environment

مصطلحات موضوعية: Àrees temàtiques de la UPC::Física, Àrees temàtiques de la UPC::Enginyeria biomèdica::Electrònica biomèdica::Radioteràpia, Drugs--Dosage, Monte Carlo method, Ionization chambers, Radiotherapy, Monte Carlo, PerFRACTION, PRIMO, Transit dosimetry, Validation, Posologia, Montecarlo, Mètode de, Cambres d'ionització, Radioteràpia

وصف الملف: application/pdf

Relation: Sánchez-Artuñedo, D. [et al.]. Validation of an in vivo transit dosimetry algorithm using Monte Carlo simulations and ionization chamber measurements. "Journal of applied clinical medical physics", 27 Octubre 2023, núm. article e14187.; http://hdl.handle.net/2117/397810

الاتاحة: http://hdl.handle.net/2117/397810
https://doi.org/10.1002/acm2.14187

المؤلفون: South Carolina Board of Pharmacy

مصطلحات موضوعية: Drugs--Dosage forms--Law and legislation--South Carolina, Injections, Intravenous--Law and legislation--South Carolina

وصف الملف: application/pdf; Document

Relation: https://dc.statelibrary.sc.gov/handle/10827/51635

الاتاحة: https://dc.statelibrary.sc.gov/handle/10827/51635

الموضوعات: Medicaid Statistics. Claims administration Kansas, Health services accessibility Statistics. Kansas, Family medicine Statistics. Kansas, Older people Statistics. Kansas, People with disabilities Statistics. Kansas, Older people Statistics. Long-term care Kansas, Nursing homes Surveys. Kansas, Waiver Statistics. Kansas, Managed care plans (Medical care) Finance. Kansas, Antipsychotic drugs Control Kansas., Antipsychotic drugs Abuse of Prevention. Kansas, Opioid abuse Prevention. Kansas, Drugs Dosage Reduction Kansas., Services de santé Statistiques. Accessibilité Kansas, Médecine familiale Statistiques. Kansas, Personnes âgées Statistiques. Kansas, Personnes handicapées Statistiques. Kansas, Personnes âgées Statistiques. Soins de longue durée Kansas, Établissements de soins, de cure, etc. Levés. Kansas, Renonciation (Droit) Statistiques. Kansas, Neuroleptiques Lutte contre Kansas., Posologie Diminution Kansas., Drugs Dosage Reduction., Employees., Expenditures, Public., Family medicine., Health services accessibility., Managed care plans (Medical care) Finance., Medicaid Claims administration., Nursing homes., Older people., Older people Long-term care., People with disabilities., Waiver., Kansas.

مصطلحات الفهرس: Statistics., Surveys.

URL: https://kgi.contentdm.oclc.org/digital/collection/p16884coll4/search/searchterm/1096283625/field/dmoclcno/mode/all/conn/all/order/pdidat/ad/desc

المؤلفون: Mostaza Prieto, José María., Suárez Fernández, Carmen., Cosín Sales, Juan., Gómez Huelgas, Ricardo., Brotons Cuixart, Carlos., Pestana Araujo, Francisco.

المساهمون: UCH. Departamento de Medicina y Cirugía, Producción Científica UCH 2022

مصطلحات موضوعية: Enfermedades cardiovasculares - Prevención, Cardiovascular system - Diseases - Prevention, Enfermedades cardiovasculares - Factores de riesgo, Tablets (Medicine), Medicamentos - Dosificación - Formas, Drugs - Dosage forms, Cardiovascular system - Diseases - Risk factors, Pastillas (Farmacia)

وصف الملف: application/pdf

Relation: Este artículo de investigación ha sido financiado por el Grupo Ferrer Internacional SA.; BMC Cardiovascular Disorders, vol. 22 (22 dec. 2022); Mostaza, J. M., Suárez-Fernández, C., Cosín-Sales, J., Gómez-Huelgas, R., Brotons, C., Araujo, F. P., Borrayo, G., Ruiz, E. & VULCANO investigators (2022). Safety and efficacy of a cardiovascular polypill in people at high and very high risk without a previous cardiovascular event: the international VULCANO randomised clinical trial. BMC Cardiovascular Disorders, vol. 22, i. 1 (22 dec.), art. 560. DOI: https://doi.org/10.1186/s12872-022-03013-w; 1471-2261 (Electrónico); http://hdl.handle.net/10637/14366; https://doi.org/10.1186/s12872-022-03013-w

الاتاحة: http://hdl.handle.net/10637/14366
https://doi.org/10.1186/s12872-022-03013-w

المؤلفون: Escudero Ortiz, Vanesa., Domínguez Leñero, Vanessa., Catalán Latorre, Ana., Rebollo Liceaga, Joseba., Sureda González, Manuel.

المساهمون: Producción Científica UCH 2022, UCH. Departamento de Ciencias Biomédicas

مصطلحات موضوعية: Medicamentos - Dosificación, Drugs - Dosage, Monitorización, Enzimas - Inhibidores, Enzyme inhibitors, Tyrosine kinase - Inhibitors, Cáncer - Farmacoterapia, Patient monitoring, Tirosina quinasa - Inhibidores, Cancer - Chemotherapy

وصف الملف: application/pdf

Relation: Este artículo de investigación ha sido financiado por la Fundación TEDECA.; Pharmaceutics, vol. 14, i. 6 (08 jun. 2022); Escudero-Ortiz, V., Domínguez-Leñero, V., Catalán-Latorre, A., Rebollo-Liceaga, J. & Sureda, M. (2022). Relevance of therapeutic drug monitoring of tyrosine kinase inhibitors in routine clinical practice: a pilot study. Pharmaceutics, vol. 14, i. 6 (08 jun.), art. 1216. DOI: https://doi.org/10.3390/pharmaceutics14061216; 1999-4923 (Electrónico); http://hdl.handle.net/10637/14344; https://doi.org/10.3390/pharmaceutics14061216

الاتاحة: http://hdl.handle.net/10637/14344
https://doi.org/10.3390/pharmaceutics14061216

المؤلفون: Rolón, Miriam., Hanna, Eustine., Vega, Celeste., Coronel, Cathia., Dea Ayuela, María Auxiliadora., Serrano López, Dolores Remedios., Lalatsa, Katerina.

المساهمون: Producción Científica UCH 2022, UCH. Departamento de Farmacia

مصطلحات موضوعية: Chagas' disease - Chemotherapy, Chagas' disease - Treatment, Chagas, Enfermedad de - Farmacoterapia, Drugs - Dosage forms, Medicamentos - Dosificación - Formas, Enfermedad de - Tratamiento

وصف الملف: application/pdf

Relation: Este artículo de investigación ha sido financiado por el Consejo Nacional de Ciencia y Tecnología (CONACYT, Paraguay), por el PRONII-CONACYT (National Incentive Program to Researchers of the National Science and Technological Council) (14-INV-022, Paraguay), por la Royal Society (RG130542) y por la University of Portsmouth, Research and Development Fund. Eustine Hanna fue apoyada por un Erasmus+ para realizar estancias de investigación en la UCM, Madrid, España.; Pharmaceutics, vol. 14, i. 9 (29 aug. 2022); 14-INV-022; RG130542; Rolon, M., Hanna, E., Vega, C., Coronel, C., Dea-Ayuela, M. A., Serrano, D. R. & Lalatsa, A. (2022). Solid nanomedicines of Nifurtimox and Benznidazole for the oral treatment of Chagas Disease. Pharmaceutics, vol. 14, i. 9 (29 aug.), art. 1822. DOI: https://doi.org/10.3390/pharmaceutics14091822; 1999-4923 (Electrónico); http://hdl.handle.net/10637/14257; https://doi.org/10.3390/pharmaceutics14091822

الاتاحة: http://hdl.handle.net/10637/14257
https://doi.org/10.3390/pharmaceutics14091822

المؤلفون: Pace, Eric, Caruana, Carmel, Bosmans, Hilde, Cortis, Kelvin, D'Anastasi, Melvin, Valentino, Gianluca

مصطلحات موضوعية: Drugs -- Dosage, Drugs -- Administration -- Computer programs, Tomography, Diagnostic imaging, Drugs -- Dose-response relationship

Relation: Pace, E., Caruana, C., Bosmans, H., Cortis, K., D'Anastasi, M. & Valentino, G. (2022). CTContour: An open-source Python pipeline for automatic contouring and calculation of mean SSDE along the abdomino-pelvic region for CT images; validation on fifteen systems. Physica Medica, 103, 190-198.; https://www.um.edu.mt/library/oar/handle/123456789/104779

الاتاحة: https://www.um.edu.mt/library/oar/handle/123456789/104779
https://doi.org/10.1016/j.ejmp.2022.10.027

المؤلفون: Mosier, Susan.

الموضوعات: Medicaid beneficiaries Statistics. Services for Kansas, Health services accessibility Statistics. Kansas, Medicaid Statistics. Claims administration Technological innovations Kansas, Long-term care of the sick Statistics. Kansas, Managed care plans (Medical care) Finance. Kansas, Managed care plans (Medical care) Statistics. Utilization Kansas, Drugs Dosage Reduction Kansas., Health care reform Law and legislation Planning. Kansas, Medicaid Management Auditing., Medicaid Management Reform., Services de santé Statistiques. Accessibilité Kansas, Soins de longue durée Statistiques. Kansas, Soins intégrés de santé Statistiques. Utilisation Kansas, Posologie Diminution Kansas., Medicaid Gestion Réforme., Drugs Dosage Reduction., Expenditures, Public., Health services accessibility., Long-term care of the sick., Managed care plans (Medical care) Finance., Kansas.

مصطلحات الفهرس: Statistics.

URL: https://kgi.contentdm.oclc.org/digital/collection/p16884coll4/search/searchterm/1005355769/field/dmoclcno/mode/all/conn/all/order/pdidat/ad/desc

المؤلفون: Randol, Michael.

الموضوعات: Medicaid beneficiaries Statistics. Services for Kansas, Medicaid Statistics. Claims administration Kansas, Medicaid Statistics. Claims administration Technological innovations Kansas, Health services accessibility Statistics. Kansas, Long-term care of the sick Planning. Kansas, Long-term care of the sick Statistics. Kansas, Managed care plans (Medical care) Finance. Kansas, Managed care plans (Medical care) Statistics. Utilization Kansas, Drugs Dosage Reduction Kansas., Health care reform Law and legislation Planning. Kansas, Medicaid Management Auditing., Medicaid Statistics. Claims administration, Services de santé Statistiques. Accessibilité Kansas, Soins de longue durée Planification Kansas., Soins de longue durée Statistiques. Kansas, Soins intégrés de santé Statistiques. Utilisation Kansas, Posologie Diminution Kansas., Drugs Dosage Reduction., Expenditures, Public., Health services accessibility., Long-term care of the sick., Long-term care of the sick Planning., Managed care plans (Medical care) Finance., Medicaid Claims administration., Kansas.

مصطلحات الفهرس: Statistics.

URL: https://kgi.contentdm.oclc.org/digital/collection/p16884coll4/search/searchterm/1005355846/field/dmoclcno/mode/all/conn/all/order/pdidat/ad/desc

Additional Titles: Senate Bill 82

المؤلفون: Randol, Michael.

الموضوعات: Drugs Dosage Law and legislation Kansas., Drugs Dosage Methodology Law and legislation Kansas., Drugs Dosage Reduction Law and legislation Kansas., Drugs Dosage Reduction Methodology Law and legislation Kansas., Drug utilization Methodology Law and legislation Kansas., Mental illness Treatment Law and legislation Kansas., Medicaid Law and legislation Kansas., Medicaid Law and legislation., Kansas.

URL: https://kgi.contentdm.oclc.org/digital/collection/p16884coll4/search/searchterm/1005143130/field/dmoclcno/mode/all/conn/all/order/pdidat/ad/desc

المساهمون: Massachusetts. Board of Registration in Pharmacy.

مصطلحات موضوعية: Drugs -- Dosage forms -- Law and legislation -- Massachusetts

وصف الملف: application/pdf

Relation: https://archives.lib.state.ma.us/handle/2452/850342; on1280422360

الاتاحة: https://archives.lib.state.ma.us/handle/2452/850342

المؤلفون: Wheeler, Graham Mark

مصطلحات موضوعية: 615.5072, Drugs--Dosage, Clinical trials

URL الوصول: https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.708029

المؤلفون: Cheng, Derek

المصدر: New Zealand herald, 16 Jul 2022; p.A18

المؤلفون: Naidu, Rajeshni

المصدر: New Zealand medical journal, 5 Aug 2022; v.135 n.1559:p.8-23

URL الوصول: https://journal.nzma.org.nz/issue-id/vol-135-no-1559-5-august-2022
https://ndhadeliver.natlib.govt.nz/delivery/DeliveryManagerServlet?dps_pid=IE83207087

الموضوعات: Drugs Dosage Reduction Kansas., Managed care plans (Medical care) Finance. Kansas, Managed care plans (Medical care) Statistics. Kansas, Home care services Kansas., Community health services Kansas., Integrated delivery of health care Kansas., Medicaid Claims administration Kansas., Health services accessibility Kansas., Older people Long-term care Kansas., Medicaid beneficiaries Services for Kansas., People with disabilities Services for Kansas., Public health Kansas., Posologie Diminution Kansas., Soins intégrés de santé Statistiques. Kansas, Soins à domicile Kansas., Prestation intégrée de soins Kansas., Services de santé Accessibilité Kansas., Personnes âgées Soins de longue durée Kansas., Personnes handicapées Services Kansas., Santé publique Kansas., Community health services., Drugs Dosage Reduction., Expenditures, Public., Health services accessibility., Home care services., Integrated delivery of health care., Managed care plans (Medical care), Managed care plans (Medical care) Finance., Medicaid Claims administration., Older people Long-term care., People with disabilities Services for., Public health., Kansas.

مصطلحات الفهرس: Statistics.

URL: https://kgi.contentdm.oclc.org/digital/collection/p16884coll4/search/searchterm/1004778516/field/dmoclcno/mode/all/conn/all/order/pdidat/ad/desc

الموضوعات: Managed care plans (Medical care) Finance. Kansas, Home care services Kansas., Community health services Kansas., Integrated delivery of health care Kansas., Medicaid Claims administration Management. Kansas, Medicaid Appropriations and expenditures. Kansas, Health services accessibility Kansas., Older people Long-term care Costs. Kansas, Drugs Dosage Reduction Kansas., Public health Costs. Kansas, Soins à domicile Kansas., Prestation intégrée de soins Kansas., Medicaid Crédits budgétaires et dépenses. Kansas, Services de santé Accessibilité Kansas., Personnes âgées Soins de longue durée Coût. Kansas, Posologie Diminution Kansas., Santé publique Coût. Kansas, Community health services., Drugs Dosage Reduction., Expenditures, Public., Health services accessibility., Home care services., Integrated delivery of health care., Managed care plans (Medical care) Finance., Public health Costs., Kansas.

مصطلحات الفهرس: Statistics.

URL: https://kgi.contentdm.oclc.org/digital/collection/p16884coll4/search/searchterm/1004778616/field/dmoclcno/mode/all/conn/all/order/pdidat/ad/desc

الموضوعات: Medicaid Kansas., Medicaid Costs. Kansas, Medicaid Cost control. Kansas, Medicaid Claims administration Kansas., Medicaid beneficiaries Services for Kansas., Drugs Costs. Kansas, Drugs Dosage Reduction Kansas., Health services accessibility Kansas., Public health Kansas., Medicaid Kansas., Medicaid Coût. Kansas, Medicaid Coût Contrôle. Kansas, Médicaments Coût. Kansas, Posologie Diminution Kansas., Services de santé Accessibilité Kansas., Santé publique Kansas., Drugs Costs., Drugs Dosage Reduction., Health services accessibility., Medicaid., Medicaid Claims administration., Medicaid Cost control., Medicaid Costs., Public health., Kansas.

URL: https://kgi.contentdm.oclc.org/digital/collection/p16884coll4/search/searchterm/1004778374/field/dmoclcno/mode/all/conn/all/order/pdidat/ad/desc